SNUH Obstetrics and Gynecology

Medicine & Life Sciences

1. Uterine Cervical Neoplasms 100%
2. Amniotic Fluid 95%
3. Ovarian Neoplasms 81%
4. Endometrial Neoplasms 63%
5. Chorioamnionitis 62%
6. Ovarian Epithelial Carcinoma 60%
7. Premature Obstetric Labor 60%
8. Pregnancy 58%
9. Oocytes 52%
10. Neoplasms 48%
11. Endometriosis 47%
12. Korea 46%
13. Fertilization in Vitro 41%
14. Preterm Premature Rupture of the Membranes 40%
15. Mothers 37%
16. Inflammation 36%
17. Survival 32%
18. Drug Therapy 31%
19. Genes 31%
20. Embryo Transfer 31%
21. Hysterectomy 30%
22. Serum 29%
23. Human Embryonic Stem Cells 27%
24. Pre-Eclampsia 27%
25. Hormones 27%
26. Recurrence 27%
27. Genotype 27%
28. Polycystic Ovary Syndrome 26%
29. Gestational Age 25%
30. Interleukin-6 24%
31. Lymph Nodes 24%
32. Confidence Intervals 24%
33. Ovary 23%
34. Membranes 23%
35. Therapeutics 22%
36. Parturition 22%
37. Platinum 21%
38. Vitrification 21%
39. Pregnant Women 21%
40. Infections 21%
41. Amniocentesis 21%
42. Fertility Preservation 20%
43. Neoplasm Metastasis 20%
44. Gonadotropin-Releasing Hormone 20%
45. Pregnancy Rate 19%
46. Progression-Free Survival 19%
47. Ovulation Induction 19%
48. Cryopreservation 19%
49. Premature Birth 18%
50. Embryonic Structures 18%
51. Pregnancy Outcome 17%
52. Newborn Infant 17%
53. Bone Density 17%
54. Pelvic Organ Prolapse 17%
55. Meta-Analysis 16%
56. Carcinoma 16%
57. Lymph Node Excision 16%
58. Cervix Uteri 16%
59. Cohort Studies 15%
60. Biomarkers 15%
61. Matrix Metalloproteinase 8 14%
62. Obstetrics 14%
63. Fetus 14%
64. In Vitro Techniques 14%
65. Fluorodeoxyglucose F18 14%
66. Gonadotropins 14%
67. Cyclooxygenase 2 14%
68. Rupture 13%
69. Positron Emission Tomography Computed Tomography 13%
70. Population 13%
71. Retrospective Studies 13%
72. Intracytoplasmic Sperm Injections 13%
73. Odds Ratio 13%
74. Umbilical Cord 13%
75. Follicle Stimulating Hormone 12%
76. Apoptosis 12%
77. Gynecology 12%
78. Proteins 12%
79. Breast Neoplasms 12%
80. Fertilization 12%
81. Follicular Fluid 12%
82. Case-Control Studies 12%
83. Multicenter Studies 12%
84. Placenta 11%
85. Alleles 11%
86. Laparoscopy 11%
87. Safety 11%
88. Fetal Blood 11%
89. Fertility 11%
90. Blastocyst 11%
91. Prospective Studies 11%
92. Paclitaxel 11%
93. Endometrium 11%
94. Polymerase Chain Reaction 11%
95. Cytokines 11%
96. Antifreeze Proteins 11%
97. Human papillomavirus 16 11%
98. Guidelines 11%
99. Uterus 10%
100. Ovarian Follicle 10%